Cognitive Function and Telemedicine-based, Village Doctor-led Care for Atrial Fibrillation
- Journal
- Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (Q1)
- Published
- 28 August 2026
- Study design
- Randomized controlled trial
- Evidence level
- Level 1, High (CEBM 1b)
- Authors
- Mingfang Li, Yang Chen, Shimeng Zhang, Ming Chu, Shu Yang, Youmei Shen, et al.
- PMID
- 42663407
- DOI
- 10.1093/europace/euag233
Why clinicians should know about it
- Picked for Cardiology and Cardiovascular Medicine (top studies of the week, 22 November 2026): AI-ECG identifies ATTR-CM with AUROC 0.84, aiding early diagnosis potentially
Abstract
BACKGROUND AND AIMS: Cognitive impairment is common among older patients with atrial fibrillation (AF). We aimed to evaluate whether baseline cognitive function modifies the effectiveness of a telemedicine-based, village doctor-led integrated care in older patients with AF. METHODS: This was a post hoc subgroup analysis of the MIRACLE-AF cluster-randomized trial conducted across 30 village clinics in China from December 2020 to May 2024. Rural participants aged ≥65 years with AF received telemedicine-based, village doctor-led integrated AF care or usual care. Participants were categorized by baseline Mini-Mental State Examination (MMSE) score into severe cognitive impairment (MMSE <18), mild-to-moderate cognitive impairment (MMSE 18-23), and preserved cognition (MMSE ≥24). The primary outcome was a composite of cardiovascular death, all stroke, hospitalization for worsening heart failure or acute coronary syndrome, and emergency visits for AF. RESULTS: Among 1,039 participants enrolled in the MIRACLE-AF trial (mean [SD] age, 75.8 [5.7] years; 460 women [44.3%]), 1,028 (98.9%) had baseline MMSE assessed (388 with MMSE <18, 305 with MMSE 18-23, and 335 with MMSE ≥24). Compared with control, the intervention reduced the risk of the primary outcome among patients with MMSE 18-23 (adjusted hazard ratio [HR], 0.56; 95% CI, 0.34-0.92), MMSE ≥24 (adjusted HR, 0.55; 95% CI, 0.32-0.93), and MMSE <18 (adjusted HR, 0.86; 95% CI, 0.54-1.35). P for interaction was 0.336. CONCLUSION: A telemedicine-based, village doctor-led integrated care model was associated with favorable outcomes across baseline cognitive strata, warranting further evaluation among cognitively vulnerable adults with AF in rural settings. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov (identifier NCT04622514).
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.